Suchergebnisse - "YO603Y8113"

PubPharm (1.117)

11

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

12

Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen

enthalten in: Viruses | 2024

von Stam, A. | Buchholtz, N. | Bierman, W. | +13

13

Daily ritonavir-boosted darunavir for viral suppression in pregnancy (DRV-P)

enthalten in: HIV medicine | 2024

von Gacic, N. | Tulloch, K. | Money, D. | +1

14

Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults

enthalten in: British journal of clinical pharmacology | 2024

von Zhang, Y. | Joshi, S. | Yazdani, P. | +6

15

Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure

enthalten in: Drug design, development and therapy | 2024

von Alberton, F. | Galli, L. | Lolatto, R. | +7

16

Modern antiretroviral regimens in pregnant women : virologic outcomes and durability

enthalten in: AIDS (London, England) | 2024

von Smith, C. | Silveira, L. | Crotteau, M. | +7

17

Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2024

von Rigo-Bonnin, R. | García-Tejada, L. | Mas-Bosch, V. | +6

18

Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen

enthalten in: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology | 2023

von Stroffolini, G. | Lazzaro, A. | Barco, A. | +9

19

Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Brooks, K. | Pau, A. | Swaim, D. | +6

20

Two-Drug Regimen Containing Darunavir : Metabolic Evaluation of an Old Dual Therapy

enthalten in: AIDS research and human retroviruses | 2023

von Farinacci, D. | Iannone, V. | D'Angelillo, A. | +4